/SILK

SILK Stock - Silk Road Medical, Inc

Q: What is the analyst price target for SILK?

Analyst price target information is not currently available for SILK.

Q: What is SILK's market cap?

Market capitalization information is not currently available for SILK.

Healthcare|Medical - Devices|NASDAQ

$27.49-0.04%

$0.01 (-0.04%) • Sep 16

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+13.9%upside

Target: $31.31

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SILK

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.54

52W High$27.51

52W Low$6.08

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$177.13M	$138.64M	$101.47M	$75.23M	$63.35M
Gross Profit	$127.09M	$100.76M	$76.03M	$53.94M	$47.43M
Gross Margin	71.7%	72.7%	74.9%	71.7%	74.9%
Operating Income	$-59,271,000	$-52,004,000	$-47,468,000	$-42,859,000	$-28,065,000
Net Income	$-55,743,000	$-58,016,000	$-50,387,000	$-50,385,000	$-56,073,000
Net Margin	-31.5%	-41.8%	-49.7%	-67.0%	-88.5%
EPS	$-1.44	$-1.62	$-1.45	$-1.53	$-2.44

Company Overview

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Visit Website

Earnings History & Surprises

SILK

Beat Rate

55%

Last 20 quarters

Avg Surprise

+0.2%

EPS vs Estimate

Beats / Misses

11/8

1 met exactly

Latest EPS

$-0.42

Q3 2024

EPS Surprise History

Q4 22

+34.1%

$-0.29vs$-0.44

Q1 23

+8.1%

$-0.34vs$-0.37

Q2 23

-10.3%

$-0.43vs$-0.39

Q3 23

+10.3%

$-0.35vs$-0.39

Q4 23

+8.3%

$-0.33vs$-0.36

Q1 24

+17.5%

$-0.33vs$-0.40

Q2 24

+10.0%

$-0.36vs$-0.40

Q3 24

-10.5%

$-0.42vs$-0.38

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2024	Aug 7, 2024	$-0.38	$-0.42	-10.5%	✗ MISS
Q2 2024	Apr 30, 2024	$-0.40	$-0.36	+10.0%	✓ BEAT
Q1 2024	Feb 28, 2024	$-0.40	$-0.33	+17.5%	✓ BEAT
Q4 2023	Nov 8, 2023	$-0.36	$-0.33	+8.3%	✓ BEAT
Q3 2023	Aug 1, 2023	$-0.39	$-0.35	+10.3%	✓ BEAT
Q2 2023	May 9, 2023	$-0.39	$-0.43	-10.3%	✗ MISS
Q1 2023	Feb 28, 2023	$-0.37	$-0.34	+8.1%	✓ BEAT
Q4 2022	Nov 8, 2022	$-0.44	$-0.29	+34.1%	✓ BEAT
Q3 2022	Jul 26, 2022	$-0.47	$-0.44	+6.4%	✓ BEAT
Q2 2022	May 4, 2022	$-0.41	$-0.48	-17.1%	✗ MISS
Q1 2022	Feb 24, 2022	$-0.40	$-0.42	-5.0%	✗ MISS
Q4 2021	Nov 9, 2021	$-0.31	$-0.40	-29.0%	✗ MISS
Q3 2021	Jul 29, 2021	$-0.37	$-0.31	+16.2%	✓ BEAT
Q2 2021	May 4, 2021	$-0.40	$-0.31	+22.5%	✓ BEAT
Q1 2021	Mar 1, 2021	$-0.30	$-0.49	-63.3%	✗ MISS
Q4 2020	Nov 10, 2020	$-0.28	$-0.31	-10.7%	✗ MISS
Q3 2020	Aug 5, 2020	$-0.38	$-0.32	+15.8%	✓ BEAT
Q2 2020	Apr 30, 2020	$-0.31	$-0.32	-3.2%	✗ MISS
Q1 2020	Feb 26, 2020	$-0.27	$-0.27	0.0%	= MET
Q4 2019	Oct 29, 2019	$-0.27	$-0.26	+3.7%	✓ BEAT

Frequently Asked Questions about SILK

What is SILK's current stock price?

Silk Road Medical, Inc (SILK) is currently trading at $27.49 per share. The stock has moved -0.04% today.

What is the analyst price target for SILK?

The average analyst price target for SILK is $31.31, based on 1 analyst.

What sector is Silk Road Medical, Inc in?

Silk Road Medical, Inc operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.

What is SILK's market cap?

Silk Road Medical, Inc has a market capitalization of $1.12 billion, making it a small-cap company.

Does SILK pay dividends?

No, Silk Road Medical, Inc does not currently pay a dividend to shareholders.